APOE4+ status increases rate of longitudinal cognitive decline in Parkinson Disease patients with low CSF Aβ42
Objective: To determine if the presence of APOEɛ4 allele (APOE4+) predicts longitudinal cognitive decline in Parkinson’s disease (PD) patients with low CSFAβ42 Background: Cognitive impairment…Olfactory deficits in the cognitive impaired de novo patients with Parkinson’s disease
Objective: To determine whether olfactory deficits may be related to the cognitive impairment in de novo Parkinson’s disease patients. Background: Hyposmia is highly prevalent in…Quantitative measures of brain MRI as a predictive factor of cognitive outcomes after Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s disease
Objective: To explore whether pre-surgical white matter lesion volume, measured quantitatively on brain MR images, is predictive of cognitive outcomes following subthalamic nucleus deep brain…Clinical Experience with Initiation of Carbidopa/Levodopa Enteral Suspension in Parkinson’s Disease Patients with Cognitive Impairment
Objective: To assess the safety and efficacy of carbidopa/levodopa enteral suspension (CLES) in Parkinson’s disease (PD) patients with cognitive impairment. Background: As Parkinson’s Disease progresses,…Rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula: a case report
Objective: To report the case of a 75-year-old woman with rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula Background: Vascular malformations…Predict cognitive decline with non-clinical markers in Parkinson’s disease
Objective: In this study, we investigated whether [123I]FP-CIT single photon emission computed tomography (SPECT) imaging measures and CSF marker profiles predict CI in PD patients…Relationship between Insulin-like Growth Factor-1 and characteristics of physical activity in patients with Parkinson’s disease
Objective: To clarify the characteristics of decreased physical activity and relationship between physical activity intensity and Insulin-like Growth Factor-1 (IGF-1) in patients with Parkinson's disease…Higher risk of cognitive impairment in Parkinson’s disease with comorbid diabetes
Objective: To determine the risk of cognitive impairment in individuals with Parkinson’s disease (PD) and diabetes. Background: Diabetes is associated with risk of cognitive impairment…Early cognitive impairment phenotype and functional connectivity in non-demented Parkinson’s disease patients
Objective: This study was designed to clarify the relationship between early cognitive decline and functional connectivity changes in non-demented Parkinson's disease (PD) patients. Background: Cognitive…Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients
Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with…
- « Previous Page
- 1
- …
- 98
- 99
- 100
- 101
- 102
- …
- 128
- Next Page »